Clinical trial
Acute Effects of Cannabigerol (CBG) on Mood and Cognition
NCT05257044 is registered in ClinicalTrials.gov with Washington State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Effects of Cannabigerol (CBG) on Mood and Cognition
- Lead sponsor
- Washington State University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 24, 2022
- Completion date
- November 28, 2023
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focus: to examine acute effects of cbg on anxiety, stress, and cognition